50242-918 : Tecentriq 840 mg/14ml Intravenous Injection, Solution

Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tecentriq
Dosage Form: Intravenous Injection, Solution
Application #: BLA761034
Rev. Date: 

NDC Package Codes:

  • 50242-918-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑918‑01) > 14 ML IN 1 VIAL, SINGLE‑USE
  • 50242-918-86: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑918‑86) > 14 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Atezolizumab

Dosage Strength:

  • 840 mg/14mL

Pharmaceutical Classes:

  • Programmed Death Receptor-1 Blocking Antibody [EPC]
  • Antibodies
  • Monoclonal
  • Humanized [CS]
  • Monoclonal [CS]
  • Antibodies [CS]
  • Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 50242-917 Tecentriq 1200 mg/20ml Intravenous Injection, Solution by Genentech, Inc.


Scan the QR code below to easily reference this data in the future:

NDC 50242-918 QR Code

< Prev: 50242-917Next: 50242-920 >

Related Discussions:

Atezolizumab drug for lung cancer
My boyfriend was diagnosed with small cell carcinoma in August while in the hospital with pneumonia. Straight out of the... 1 reply

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.